ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
chemrxiv-COVID-19 manuscript-27320.pdf (1.38 MB)

The Role of Folic Acid in the Management of Respiratory Disease Caused by COVID-19

preprint
submitted on 26.03.2020, 17:53 and posted on 30.03.2020, 16:16 by Zahra Sheybani, Maryam Heydari Dokoohaki, Manica Negahdaripour, Mehdi Dehdashti, Hassan Zolghadr, Mohsen Moghadami, Seyed Masoom Masoompour, Amin Reza Zolghadr

Entrance of coronavirus into cells happens through the spike proteins on the virus surface, for which the spike protein should be cleaved into S1 and S2 domains. This cleavage is mediated by furin, which can specifically cleave Arg-X-X-Arg↓ sites of the substrates. Furin, a member of proprotein convertases family, is moved from the trans-Golgi network to the cell membrane and activates many precursor proteins. A number of pathological conditions such as atherosclerosis, cancer, and viral infectious diseases, are linked with the impaired activity of this enzyme.

Despite the urgent need to control COVID-19, no approved treatment is currently known. Here, folic acid (folate), a water-soluble B vitamin, is introduced for the first time for the inhibition of furin activity. As such, folic acid, as a safe drug, may help to prevent or alleviate the respiratory involvement associated with COVID-19.


History

Email Address of Submitting Author

arzolghadr@shirazu.ac.ir

Institution

Shiraz University

Country

Iran

ORCID For Submitting Author

0000-0002-6289-3794

Declaration of Conflict of Interest

no conflict of interest

Exports

Logo branding

Exports